The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients

Kesim M., Tiryaki A., Kadioglu M., MUCI E., KALYONCU N. İ., YARIŞ E.

JOURNAL OF RESEARCH IN MEDICAL SCIENCES, cilt.16, sa.12, ss.1525-1531, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 12
  • Basım Tarihi: 2011
  • Dergi Adı: JOURNAL OF RESEARCH IN MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1525-1531
  • Anahtar Kelimeler: Sertraline, Insulin, Glucose, Lipid, HbA1C, SEROTONIN REUPTAKE INHIBITORS, DISORDER, ANTIDEPRESSANTS, SENSITIZATION, CHOLESTEROL, FLUOXETINE, GLYCEMIA, SUCROSE, MEAL, RATS
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

BACKGROUND: In this study, we aimed to investigate the possible effects of sertraline on blood glucose and lipid levels as risk factors for cardiovascular disease in depressive patients.